Celestica Q1 Surge Confirms AI Demand, But Risks Remain

What happened

Celestica's Q1 2026 results showed revenue up 53% YoY to $4.05B, with CCS segment growing 76% and enterprise jumping 101%, reinforcing the AI infrastructure build-out narrative. The company raised its 2026 guidance to $19B revenue and $10.15 adjusted EPS, driving the stock to a ~43x P/E. However, the DeepValue Master Report flags extreme customer concentration (35%/15%/15% from three accounts) and a $1B capex ramp that hinges on flawless execution amid utility/grid bottlenecks. While near-term demand is robust, the report assigns a base case of $390 and bear case of $260, citing the risk of a utilization-driven earnings air pocket if deployments slip. The consensus excitement about "AI picks-and-shovels" may be pricing in perfect execution, leaving limited margin of safety.

Implication

The Q1 beat and raised guidance confirm that hyperscaler AI infrastructure spending is accelerating, benefiting Celestica's CCS segment directly. However, the stock's 43x P/E and 34x EV/EBITDA leave no room for error, and the DeepValue report's analysis of 79% top-10 customer concentration and $314M in receivables sales signals potential cash-flow fragility during the capex ramp. Investors should monitor the next quarterly filings for any experienced-language around program delays due to power/grid constraints, which would trigger the report's downside scenario toward $260. The report's base case of $390 implies limited upside from current ~$361, suggesting a better risk-reward entry near $300. Until CCS margin stability and working capital normalization are proven, maintaining a wait-and-see position is prudent.

Thesis delta

The news reinforces the near-term demand momentum, aligning with the bullish scenario in the DeepValue report, but does not shift the overall thesis. The core concerns—extreme customer concentration, a massive capex step-up, and reliance on non-demand factors like utility interconnection—remain unchanged. Consequently, the "WAIT" rating with an attractive entry at $300 remains appropriate, as the current price already reflects the positive Q1 results without a safety margin.